{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T10:52:08Z","timestamp":1791975128507,"version":"4.4.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.ejso.2026.112198","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:02:43Z","timestamp":1791475363000},"page":"112198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Long-term survival after HIPEC with mitomycin C versus oxaliplatin in patients with colorectal peritoneal metastases"],"prefix":"10.1016","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-1997-4220","authenticated-orcid":false,"given":"Lizzel","family":"van der Snee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arend G.J.","family":"Aalbers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1086-8108","authenticated-orcid":false,"given":"Petur","family":"Snaebjornsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brechtje A.","family":"Grotenhuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia D.","family":"Bottenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3678-3222","authenticated-orcid":false,"given":"Marta","family":"Lopez-Yurda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Bolhuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8444-202X","authenticated-orcid":false,"given":"Max J.","family":"Lahaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1193-0214","authenticated-orcid":false,"given":"Niels F.M.","family":"Kok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2026.112198_bib1","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1038\/bjc.2013.82","article-title":"Impact of peritoneal carcinomatosis in the disease history of colorectal cancer management: a longitudinal experience of 2406 patients over two decades","volume":"108","author":"Kerscher","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejso.2026.112198_bib2","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1002\/ijc.25596","article-title":"Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: a population-based study","volume":"128","author":"Lemmens","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejso.2026.112198_bib3","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/bjs.8679","article-title":"Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer","volume":"99","author":"Segelman","year":"2012","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejso.2026.112198_bib4","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.ejso.2020.11.135","article-title":"Increase in the incidence of synchronous and metachronous peritoneal metastases in patients with colorectal cancer: a nationwide study","volume":"47","author":"Lurvink","year":"2021","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2026.112198_bib5","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/S1470-2045(16)30490-9","article-title":"Treatment of colorectal peritoneal metastases requires multidisciplinary efforts","volume":"17","author":"Goere","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2026.112198_bib6","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1200\/JCO.2008.19.7160","article-title":"Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin","volume":"27","author":"Elias","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejso.2026.112198_bib7","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1186\/s12885-019-5545-0","volume":"19","author":"Rovers","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejso.2026.112198_bib8","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S1470-2045(20)30599-4","article-title":"Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial","volume":"22","author":"Quenet","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2026.112198_bib9","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ejso.2017.10.216","article-title":"Safety of intraperitoneal Mitomycin C versus intraperitoneal oxaliplatin in patients with peritoneal carcinomatosis of colorectal cancer undergoing cytoreductive surgery and HIPEC","volume":"44","author":"van Eden","year":"2018","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2026.112198_bib10","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1016\/j.ejso.2020.04.018","article-title":"Long-term survival after hyperthermic intraperitoneal chemotherapy using mitomycin C or oxaliplatin in colorectal cancer patients with synchronous peritoneal metastases: a nationwide comparative study","volume":"46","author":"Bakkers","year":"2020","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2026.112198_bib11","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.ejso.2026.112198_bib12","series-title":"R: a language and environment for statistical computing","year":"2025"},{"key":"10.1016\/j.ejso.2026.112198_bib13","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1007\/s11605-019-04447-y","article-title":"Oxaliplatin versus mitomycin C following complete cytoreduction for colorectal peritoneal metastases: a comparative study","volume":"24","author":"Narasimhan","year":"2020","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.ejso.2026.112198_bib14","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/bjs5.50179","article-title":"Meta-analysis of prognostic factors for patients with colorectal peritoneal metastasis undergoing cytoreductive surgery and heated intraperitoneal chemotherapy","volume":"3","author":"Hallam","year":"2019","journal-title":"BJS Open"},{"key":"10.1016\/j.ejso.2026.112198_bib15","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/jso.23728","article-title":"The American society of peritoneal surface malignancies evaluation of HIPEC with mitomycin C versus oxaliplatin in 539 patients with colon cancer undergoing a complete cytoreductive surgery","volume":"110","author":"Prada-Villaverde","year":"2014","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ejso.2026.112198_bib16","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/jso.23546","article-title":"The use of oxaliplatin or mitomycin C in HIPEC treatment for peritoneal carcinomatosis from colorectal cancer: a comparative study","volume":"109","author":"Hompes","year":"2014","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ejso.2026.112198_bib17","doi-asserted-by":"crossref","DOI":"10.1093\/bjsopen\/zraa075","article-title":"Effect of oxaliplatin-based chemotherapy on chemosensitivity in patients with peritoneal metastasis from colorectal cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: proof-of-concept study","volume":"5","author":"Prabhu","year":"2021","journal-title":"BJS Open"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326008176?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326008176?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T10:26:52Z","timestamp":1791973612000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798326008176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2027,1]]}},"alternative-id":["S0748798326008176"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2026.112198","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term survival after HIPEC with mitomycin C versus oxaliplatin in patients with colorectal peritoneal metastases","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2026.112198","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112198"}}